SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-042820
Filing Date
2022-04-05
Accepted
2022-04-05 16:47:57
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2211420-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2211420-5_4seq1.xml 4 3929
  Complete submission text file 0001104659-22-042820.txt   5266
Mailing Address 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10024
Business Address
Hoberman Kenneth (Reporting) CIK: 0001573722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 22807733

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations